PhoenixBio (6190) Stock Overview

PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.

6190 Stock Information

Symbol

6190

Address

3-4-1 KagamiyamaHigashihiroshima, 739-0046Japan

Founded

Trading hours

Website

https://www.phoenixbio.co.jp

Country

🇯🇵 Japan

Phone Number

81 8 2431 0016

PhoenixBio (6190) Price Chart

PhoenixBio Overview: Key Details and Summary

Stock data	2023	Change
Price	$3.39	N/A
Market Cap	$11.50M	N/A
Shares Outstanding	3.40M	2.88%
Employees	65.00	N/A
Shareholder Equity	1.51B	82.87%

Valuation	2023	Change
P/E Ratio	0.03	N/A
P/S Ratio	0.79	N/A
P/B Ratio	0.01	N/A

Growth	2023	Change
Return on Equity	0.0022	N/A

Earnings	2023	Change
Revenue	$14.47M	N/A
Earnings	$3.36M	N/A
EPS	97.29	N/A
Earnings Yield	28.73	N/A
Gross Margin	0.7328	N/A
Operating Margin	0.2394	N/A
Net income margin	0.2323	N/A

Financial Strength	2023	Change
Total Assets	$20.56M	N/A
Total Debt	$7.70M	N/A
Cash on Hand	$10.60M	N/A
Debt to Equity	0.0068	-43.36%
Cash to Debt	$1.38	7.88%
Current Ratio	$1.78	-57.83%